Waverton Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Waverton Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-472,368	Closed	-$32.7M	–	76
2023 Q1	$32.7M	Buy	472,368 +65,494	+16%	+$4.62M	1.01%	26
2022 Q4	$29.3M	Buy	406,874 +27,990	+7%	+$2.11M	1.08%	28
2022 Q3	$26.9M	Buy	378,884 +194,634	+106%	+$14.1M	1.1%	25
2022 Q2	$14.2M	Buy	184,250 +152,650	+483%	+$11.6M	0.55%	33
2022 Q1	$2.31M	Buy	+31,600	New	+$2.12M	0.08%	60
2016 Q4	–	Sell	-912,768	Closed	-$49.2M	–	111
2016 Q3	$49.2M	Sell	912,768 -18,506	-2%	-$1.19M	3.31%	11
2016 Q2	$68.5M	Buy	931,274 +33,231	+4%	+$2.35M	5.14%	3
2016 Q1	$57.4M	Buy	898,043 +119,425	+15%	+$7.53M	4.39%	6
2015 Q4	$53.6M	Buy	+778,618	New	+$51.5M	4.03%	6

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Waverton Investment Management's BMY Position: Q2 2023 in Review

Waverton Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 472,368 shares — an estimated $32.7M sold.

Waverton Investment Management first reported a position in BMY in Q4 2015 and held it in 9 quarters. The position peaked at $68.5M in Q2 2016. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Waverton Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Waverton Investment Management sold 472,368 Bristol-Myers Squibb shares in Q2 2023, an estimated $32.7M.
Waverton Investment Management first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 9 quarters.
Waverton Investment Management's Bristol-Myers Squibb position peaked at $68.5M in Q2 2016.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Waverton Investment Management's 13F filing for Q2 2023, filed 2 Aug 2023.